Medpace Holdings, Inc.
MEDP
株式のランク
#1305
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
株価
$622.03
最終同期: 2026-10-20
時価総額
$17.36B
変化（1日）
0.38%
変化（1年）
14.00%
国
US
取引 Medpace Holdings, Inc. (MEDP)
カテゴリー
Healthcare
Medpace Holdings, Inc.（MEDP）のP/S比率
October 2026 時点のP/S比率 TTM: 6.19
Medpace Holdings, Inc. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 6.19 です。2024 年末時点でのP/S比率は 4.88 でした。
Medpace Holdings, Inc. の P/S 比率の履歴（2013 ～ 2026）
各年末時点のP/S比率
| 年 | P/S比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 6.19 | -3.34% |
| 2025 | 6.40 | 31.31% |
| 2024 | 4.88 | -2.35% |
| 2023 | 4.99 | 5.98% |
| 2022 | 4.71 | -31.03% |
| 2021 | 6.83 | 27.53% |
| 2020 | 5.36 | 52.92% |
| 2019 | 3.50 | 31.19% |
| 2018 | 2.67 | -17.76% |
| 2017 | 3.25 | 6.33% |
| 2016 | 3.05 | -0.45% |
| 2015 | 3.07 | 8.77% |
| 2014 | 2.82 | -27.78% |
| 2013 | 3.91 | 0.00% |
同業他社のP/S比率
| 企業 | P/S比率 | P/S比率の差 | 国 |
|---|---|---|---|
| 5.37 | -13.16% |
US
|
|
| 6.29 | 1.72% |
US
|
|
| 21.02 | 239.79% |
US
|
|
| - | - |
CN
|
|
| 6.67 | 7.76% |
US
|
